Displaying 1301 - 1320 of 1595
FTC/DOJ Hearings on Health Care And Competition Law and Policy
Third Session of FTC/DOJ Health Care and Competition Law and Policy Hearings Begins Wednesday, April 9
Quest Diagnostics Inc.orporated and Unilab Corporation
Quest Diagnostics settled FTC charges that its proposed acquisition of Unilab Corporation would substantially increase concentration in the clinical laboratory testing services market by agreeing to divest clinical laboratory testing assets in Northern California to Laboratory Corporation of America.
Federal Judge Issues Record $7 Million Fine Against Boston Scientific Corporation
Boston Scientific Corporation, U.S.
FTC/DOJ Hearings on Health Care And Competition Law and Policy
FTC/DOJ Hearings on Health Care and Competition Law and Policy
Second Session of the FTC/ DOJ Health Care and Competition Law and Policy Hearings Begins on Wednesday, March 26, 2003
Announced Actions for March 18, 2003
FTC/DOJ Hearings on Health Care And Competition Law and Policy
FTC Charges Bristol-Myers Squibb with Pattern of Abusing Government Processes to Stifle Generic Drug Competition
Health Care and Competition Law and Policy Hearings
FTC/DOJ Release Agenda for Upcoming Sessions of Joint Health Care Hearings
FTC/DOJ Release Agenda for First Session of Health Care Hearings
FTC Staff Issues Advisory Opinion Regarding Proposed Formation of Physicians' Healthcare Advocacy Group in Dayton, Ohio
Baxter International Inc., and Wyeth, In the Matter of
Baxter settled Commission concerns stemming from its $316 million proposed acquisition of Wyeth Corporation's generic injectable drug business and agreed to divest several pharmaceutical products. The Commission charged that the acquisition would reduce competition in the manufacture and sale of propofol (a general anesthetic); new injectable iron replacement therapies; metocloprarnide (used to treat nausea); and vecuronium and pancuronium (neuromuscular blocking agents used to temporarily freeze muscles during surgery). The consent order requires divestitures in each of the pharmaceutical markets.
Announced Action for January 29, 2003
FTC/DOJ Hearings to Focus on Health Care And Competition Law and Policy
SmithKline Beecham Corp. v. Apotex Corp.
Displaying 1301 - 1320 of 1595